Starpharma Holdings Limited ( Starpharma)

Primary tabs

Starpharma's picture

Management

Contact Address

About Starpharma Holdings Limited

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications.

Starpharma press release, blog etc

Tue, 02/20/2024 - 10:27 VivaGel BV US FDA Appeal Outcome (ASX Announcement)
Fri, 12/23/2022 - 19:03 Starpharma receives $7.1M R&D tax incentive refund (ASX announcement)
Wed, 12/21/2022 - 00:00 Resignation of CFO / Company Secretary
Tue, 12/13/2022 - 10:00 Positive AZD0466 clinical data presented by AstraZeneca (ASX Announcement)
Mon, 09/12/2022 - 11:08 Starpharma presents promising additional clinical data for DEP cabazitaxel in prostate cancer
Mon, 09/12/2022 - 09:30 Starpharma presents additional clinical data for DEP cabazitaxel in prostate cancer (ASX Announcement)
Wed, 08/10/2022 - 07:46 Starpharma signs new DEP agreement with MSD (ASX Announcement)
Wed, 08/10/2022 - 01:28 Starpharma signs new DEP agreement with MSD
Thu, 06/30/2022 - 07:04 VIRALEZE relaunched by LloydsPharmacy in the UK (ASX Announcement)
Wed, 05/18/2022 - 03:27 SPL7013 in VIRALEZE virucidal against influenza A and B (ASX Announcement)
Wed, 04/27/2022 - 14:43 Starpharma to present DEP at Boston ADC summit (ASX Announcement)
Fri, 04/01/2022 - 03:53 VIRALEZE to relaunch in the UK (ASX Announcement)
Fri, 03/04/2022 - 05:02 Response to media article (ASX Announcement)
Tue, 03/01/2022 - 08:22 SPL7013 in VIRALEZE virucidal against Omicron (ASX Announcement)
Thu, 02/24/2022 - 11:33 Dr Jeff Davies appointed as non-executive director (ASX Announcement)
Mon, 02/21/2022 - 07:29 Starpharma Interim Report and Half-Year Financial Results (ASX Announcement)
Thu, 02/03/2022 - 09:34 VIRALEZE sales and distribution in Saudi Arabia and GCC (ASX Announcement)
Thu, 01/20/2022 - 08:18 Starpharma receives $7.7M R&D tax incentive refund (ASX Announcement)
more

InfoBox

HomePagewww.starpharma.com